Metabolically healthy obesity: Misleading phrase or healthy phenotype?
European Journal of Internal Medicine · 2023-05 · 111 · 5-20
DOI: 10.1016/j.ejim.2023.02.025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Internal Medicine, 2023-05. Verfasst von Cem Tanriover und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Koc University School of Medicine, Istanbul, Turkey. Hauptthemen laut MEDLINE: Obesity, Metabolically Benign, Diabetes Mellitus, Type 2, Metabolic Syndrome. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 204 Literaturangaben.
Abstract (Originalsprache)
Obesity is a heterogenous condition with multiple different phenotypes. Among these a particular subtype exists named as metabolically healthy obesity (MHO). MHO has multiple definitions and its prevalence varies according to study. The potential mechanisms underlying the pathophysiology of MHO include the different types of adipose tissue and their distribution, the role of hormones, inflammation, diet, the intestinal microbiota and genetic factors. In contrast to the negative metabolic profile associated with metabolically unhealthy obesity (MUO), MHO has relatively favorable metabolic characteristics. Nevertheless, MHO is still associated with many important chronic diseases including cardiovascular disease, hypertension, type 2 diabetes, chronic kidney disease as well as certain types of cancer and has the risk of progression into the unhealthy phenotype. Therefore, it should not be considered as a benign condition. The major therapeutic alternatives include dietary modifications, exercise, bariatric surgery and certain medications including glucagon-like peptide-1 (GLP-1) analogs, sodium-glucose cotransporter-2 (SGLT-2) inhibitors and tirzepatide. In this review, we discuss the significance of MHO while comparing this phenotype with MUO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Koc University School of Medicine, Istanbul, Turkey.
- Department of Medicine, Nazarbayev University School of Medicine, Astana, Kazakhstan; Clinical Academic Department of Internal Medicine, CF "University Medical Center", Astana, Kazakhstan.
- Department of Cardiology, Toranomon Hospital, Tokyo, Japan.
- Department of Nephrology, Rigshospitalet, Inge Lehmanns Vej 7, Copenhagen 2100, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Center, Loaction VUMC, Amsterdam, the Netherlands.
- Department of Medicine, Division of Nephrology, Koc University School of Medicine, Istanbul 34010, Turkey. Electronic address: mkanbay@ku.edu.tr.
Zitieren
APA
Tanriover, C., Copur, S., Gaipov, A., Ozlusen, B., Akcan, R. E., Kuwabara, M., Hornum, M., Van Raalte, D. H., & Kanbay, M. (2023). Metabolically healthy obesity: Misleading phrase or healthy phenotype?. European Journal of Internal Medicine, 111, 5-20. https://doi.org/10.1016/j.ejim.2023.02.025
Vancouver
Tanriover C, Copur S, Gaipov A, Ozlusen B, Akcan RE, Kuwabara M, et al. Metabolically healthy obesity: Misleading phrase or healthy phenotype?. European Journal of Internal Medicine. 2023;111:5-20. doi:10.1016/j.ejim.2023.02.025
BibTeX
@article{Tanriover2023,
author = {Tanriover, Cem and Copur, Sidar and Gaipov, Abduzhappar and Ozlusen, Batu and Akcan, Rustu E and Kuwabara, Masanari and Hornum, Mads and Van Raalte, Daniel H and Kanbay, Mehmet},
title = {Metabolically healthy obesity: Misleading phrase or healthy phenotype?},
journal = {European Journal of Internal Medicine},
year = {2023},
volume = {111},
pages = {5--20},
doi = {10.1016/j.ejim.2023.02.025}
}
EUVIMED